ARCHIVES

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

Five Proposals Submitted In Recompetition Of FCRF Operations/Support Contract; Now Under Review

January 2, 1987

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

Ethics Commission Acknowledges Weak Case For Mandatory Patient Compensation

April 23, 1982

NCCS Networker Volume 2 Issue 4, Fall 1988

September 13, 1988

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

April 10, 2009